A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

Objectives:To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). Design:We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15–30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. Results:The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Conclusion:Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission.

[1]  P. Bacchetti,et al.  Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis , 2001, The Lancet.

[2]  K. Watkins,et al.  Determinants of condom use among intravenous drug users , 1993, AIDS.

[3]  D. Vlahov,et al.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.

[4]  A. Bandura.  Social Foundations of Thought and Action , 1986 .

[5]  R. Garfein,et al.  Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). , 2007, Drug and alcohol dependence.

[6]  J. T. Wulu,et al.  Regression analysis of count data , 2002 .

[7]  D. Vlahov,et al.  Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. , 2003, American journal of epidemiology.

[8]  W A Fisher,et al.  Changing AIDS-risk behavior. , 1992, Psychological bulletin.

[9]  D. Vlahov,et al.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[10]  Russell D. Wolfinger,et al.  Fitting Nonlinear Mixed Models with the New NLMIXED Procedure , 1999 .

[11]  J. Parry,et al.  Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study , 2004, BMJ : British Medical Journal.

[12]  W. B. Hansen.  School-based substance abuse prevention: a review of the state of the art in curriculum, 1980-1990. , 1992, Health education research.

[13]  D S Metzger,et al.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. , 2000, American journal of epidemiology.

[14]  R. Garfein,et al.  Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. , 2007, Drug and alcohol dependence.

[15]  Susan G. Sherman,et al.  The role of sexual transmission of HIV infection among injection and non-injection drug users , 2003, Journal of Urban Health.

[16]  A. Lazzarin,et al.  Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. , 1992, American journal of epidemiology.

[17]  Q. Vuong.  Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses , 1989 .

[18]  D. Vlahov,et al.  Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. , 2001, Journal of substance abuse.

[19]  J. Grund,et al.  The limitations of the concept of needle sharing: the practice of frontloading. , 1990, AIDS.

[20]  M. Busch,et al.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.

[21]  R J Mills,et al.  Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. , 1998, Public health reports.

[22]  C. Latkin,et al.  Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. , 1998, Public health reports.

[23]  D. Vlahov,et al.  Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. , 1995, Archives of internal medicine.

[24]  M. Lindegren,et al.  Revised guidelines for HIV counseling, testing, and referral ; and Revised recommendations for HIV screening of pregnant women , 2001 .

[25]  D. D. Des Jarlais,et al.  Effects of outreach intervention on risk reduction among intravenous drug users. , 1990, AIDS education and prevention : official publication of the International Society for AIDS Education.

[26]  R. Curtis,et al.  Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. , 1995, NIDA research monograph.

[27]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.

[28]  Laurence H. Baker,et al.  Clinical Trials: Design, Conduct, and Analysis , 1987 .

[29]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[30]  R. Stephens,et al.  Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. , 1991, American journal of public health.

[31]  M. Barnard.  Needle sharing in context: patterns of sharing among men and women injectors and HIV risks. , 1993, Addiction.

[32]  D. Vlahov,et al.  Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. , 2001, Archives of internal medicine.

[33]  B. Hirschel,et al.  Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. , 1992, AIDS.

[34]  M. Schechter,et al.  Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. , 1997, Addiction.

[35]  D. Metzger,et al.  Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. , 2005, Addiction.

[36]  M. Kauth.  HIV Sexual Risk Reduction among College Women: Applying a Peer Influence Model. , 1993 .

[37]  R. Dwyer,et al.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study , 1998, BMJ.

[38]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[39]  D. Vlahov,et al.  Correlates of Hepatitis C Virus Infections among Injection Drug Users , 1995, Medicine.

[40]  C. Morrison,et al.  AIDS education for drug abusers: evaluation of short-term effectiveness. , 1992, American journal of public health.

[41]  R. Coutinho,et al.  Interventions to prevent HIV risk behaviors. , 1997, NIH consensus statement.

[42]  R. Coutinho,et al.  The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. , 1992, American journal of epidemiology.

[43]  D. Main,et al.  Preventing HIV infection among adolescents: evaluation of a school-based education program. , 1994, Preventive medicine.

[44]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[45]  Heather Miller,et al.  Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.

[46]  H. Hagan.  Public health and changes in illicit drug prices. , 2001, American journal of public health.

[47]  J. Barry,et al.  Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin , 2003, Journal of epidemiology and community health.

[48]  A. Baron,et al.  Drug Sharing Among Heroin Networks: Implications for HIV and Hepatitis B and C Prevention , 2005, AIDS and Behavior.

[49]  S. M. Rogers,et al.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. , 1998, Science.

[50]  Nick Crofts,et al.  Hepatitis C virus infection among a cohort of Victorian injecting drug users , 1993, The Medical journal of Australia.

[51]  C. Bréchot.  Hepatitis C virus , 1996, Digestive Diseases and Sciences.

[52]  D. Vlahov,et al.  Association between injection practices and duration of injection among recently initiated injection drug users. , 2004, Drug and alcohol dependence.

[53]  R. Wolitski,et al.  Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials , 2006, AIDS.

[54]  J. Kelly,et al.  HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. , 1991, American journal of public health.